Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Status unconfirmed · Phase 3

Conditions studied: Fibrocystic Disease of Breast, Fibrocystic Changes of Breast, Fibrocystic Mastopathy, Pain

In brief

* History of clinical breast pain for at least the last six months. * At least six days of moderate or severe breast pain per cycle. * Fibrosis, cysts, nodules involving at least 25% of the surface of one breast. * Euthyroid with no prior history of thyroid disease. * Six months of daily therapy with molecular iodine. * Placebo controlled vs active (1:1).

Key facts

Study ID
NCT00237523
Run by
Symbollon Pharmaceuticals
People needed
175
Starts
2005-07-01
Expected to finish
2008-03-01
Last updated by the study team
2007-06-18

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.